nanoparticle contrast agents (BBS Nanotech)

N/A

Report date: 2025/03/20 14:56:49

Base Information

Drug Namenanoparticle contrast agents (BBS Nanotech)
Drug Alias Namechitosan based nanoparticles labelled with [18F]-4-fluorobenzaldehyde
ClassificationDiagnostic agent (In vivo)
Mechanisms of ActionPositron-emission tomography enhancers
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryHungary
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBBS Nanotechnology Llc
China Registration ClassN/A

Develop Information

Active CompaniesBBS Nanotechnology Llc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A